Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci

被引:69
作者
Woodford, N [1 ]
机构
[1] Cent Publ Hlth Lab, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England
关键词
D O I
10.1089/10766290152652774
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Five genotypes of acquired glycopeptide resistance have been documented in enterococci, with vanA and vanB being the most globally widespread and prevalent. Resistance results from the production of peptidoglycan precursors with reduced binding affinity for glycopeptides and is encoded by complex clusters of van genes. The prototype VanA element is Tn1546, a 101.8-kb transposon that carries the vanRSHAXYZ genes. Diverse VanA elements exist, but all share the vanRSHAX cluster and are believed to be derived from a Tn1546 progenitor. The sequences of these genes are remarkably conserved, with only a few point mutations identified. VanA elements do however vary by the presence of deletions and insertion sequences (IS) in nonessential genes (orf1, orf2, vanY, and vanZ) and intergenic regions. IS transposition probably plays a key role in VanA element evolution. By contrast vanB gene clusters show greater sequence divergence. Three vanB alleles have been reported, of which vanB2 appears to be the most widespread, generally as part of Tn5382 and related elements. To date, only four Enterococcus faecium strains with VanD resistance have been reported, and each contained a distinct vanD allele. The VanE and VanG types have each been identified in single strains of Enterococcus faecalis. The existence of distinct genotypes, together with the allelic nature of vanB and vanD, suggests that van clusters have transferred to enterococci on multiple occasions from undefined donor species, with subsequent horizontal dissemination, particularly of VanA and VanB elements, among enterococci. Characterization of glycopeptide resistance elements yields information on their evolution and broadens our insights into the epidemiology of resistant enterococci.
引用
收藏
页码:229 / 236
页数:8
相关论文
共 64 条
  • [11] Genetic linkage of the vanB2 gene cluster to Tn5382 in vancomycin-resistant enterococci and characterization of two novel insertion sequences
    Dahl, KH
    Lundblad, EW
    Rokenes, TP
    Olsvik, O
    Sundsfjord, A
    [J]. MICROBIOLOGY-SGM, 2000, 146 : 1469 - 1479
  • [12] Characterization of a divergent vanD-type resistance element from the first glycopeptide-resistant strain of Enterococcus faecium isolated in Brazil
    Dalla Costa, LM
    Reynolds, PE
    Souza, HAPHM
    Souza, DC
    Palepou, MFI
    Woodford, N
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) : 3444 - 3446
  • [13] Effects of the movement of insertion sequences on the structure of VanA glycopeptide resistance elements in Enterococcus faecium
    Darini, ALC
    Palepou, MFI
    Woodford, N
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (05) : 1362 - 1364
  • [14] Darini ALD, 1999, ANTIMICROB AGENTS CH, V43, P995
  • [15] Darini ALD, 1999, FEMS MICROBIOL LETT, V173, P341
  • [16] Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcus faecium in the pediatric oncology unit of a New York City Hospital
    De Lencastre, H
    Brown, AE
    Chung, M
    Armstrong, D
    Tomasz, A
    [J]. MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1999, 5 (02): : 113 - 129
  • [17] Prevalence and molecular epidemiology of glycopeptide-resistant enterococci in Belgian renal dialysis units
    Descheemaeker, P
    Ieven, M
    Chapelle, S
    Lammens, C
    Hauchecorne, M
    Wijdooghe, M
    Vandamme, P
    Goossens, H
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (01) : 235 - 241
  • [18] Comparison of glycopeptide-resistant Enterococcus faecium isolates and glycopeptide resistance genes of human and animal origins
    Descheemaeker, PRM
    Chapelle, S
    Devriese, LA
    Butaye, P
    Vandamme, P
    Goossens, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) : 2032 - 2037
  • [19] DOUGHERTY TJ, 1999, CURR OPIN ANTIINFECT, V1, P18
  • [20] Vancomycin resistance: Status quo and quo vadis
    Endtz, HP
    van den Braak, N
    Verbrugh, HA
    van Belkum, A
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (10) : 683 - 690